ORIC PHARMACEUTICALS, INC. Earnings Per Share (Basic)
ORIC PHARMACEUTICALS, INC. (ORIC) reported Earnings Per Share (Basic) of -$0.38 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.38.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.34.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.30.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.33.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$1.47.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$1.83.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.96.
- ORIC PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$2.25.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.38 10-Q · filed 2026-08-03 | -$0.72 10-Q · filed 2026-08-03 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2026-03-31 | -$0.34 10-Q · filed 2026-05-04 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.47 10-K · filed 2026-02-23 |
| 2025-09-30 | -$0.33 10-Q · filed 2025-11-13 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.20 10-Q · filed 2025-11-13 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-06-30 | -$0.47 10-Q · filed 2026-08-03 | -$0.89 10-Q · filed 2026-08-03 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.89 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-03-31 | -$0.42 10-Q · filed 2026-05-04 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-05-04 |
| 2024-12-31 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.83 10-K · filed 2026-02-23 |
| 2024-09-30 | -$0.49 10-Q · filed 2025-11-13 | -$0.94 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.32 10-Q · filed 2025-11-13 | -$1.80 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-06-30 | -$0.45 10-Q · filed 2025-08-12 | -$0.83 10-Q · filed 2025-08-12 | -$1.31 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.75 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.37 10-Q · filed 2025-05-05 | -$0.85 derived: net income ÷ weighted average shares · filed 2025-05-05 | -$1.30 derived: net income ÷ weighted average shares · filed 2025-05-05 | -$1.79 derived: net income ÷ weighted average shares · filed 2025-05-05 |
| 2023-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$0.94 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$1.43 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$1.96 10-K · filed 2025-02-18 |
| 2023-09-30 | -$0.44 10-Q · filed 2024-11-12 | -$0.94 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.46 10-Q · filed 2024-11-12 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.50 10-Q · filed 2024-08-12 | -$1.03 10-Q · filed 2024-08-12 | -$1.55 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$2.17 derived: net income ÷ weighted average shares · filed 2024-08-12 |
| 2023-03-31 | -$0.53 10-Q · filed 2024-05-06 | -$1.05 derived: net income ÷ weighted average shares · filed 2024-05-06 | -$1.67 derived: net income ÷ weighted average shares · filed 2024-05-06 | -$2.19 derived: net income ÷ weighted average shares · filed 2024-05-06 |
| 2022-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$1.15 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$2.25 10-K · filed 2024-03-11 |
| 2022-09-30 | -$0.63 10-Q · filed 2023-11-06 | -$1.14 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$1.73 10-Q · filed 2023-11-06 | -$2.31 derived: net income ÷ weighted average shares · filed 2023-11-06 |
| 2022-06-30 | -$0.51 10-Q · filed 2023-08-10 | -$1.10 10-Q · filed 2023-08-10 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$2.15 derived: net income ÷ weighted average shares · filed 2023-08-10 |
| 2022-03-31 | -$0.59 10-Q · filed 2023-05-08 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-05-08 | -$1.64 derived: net income ÷ weighted average shares · filed 2023-05-08 | -$2.21 derived: net income ÷ weighted average shares · filed 2023-05-08 |
| 2021-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.62 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.07 10-K · filed 2023-03-16 |
| 2021-09-30 | -$0.47 10-Q · filed 2022-11-07 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$1.49 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$0.57 10-Q · filed 2022-08-11 | -$1.02 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |